Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin's disease

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5507-5513

  Hsu, Pei Ling ^a   Hsu, Su Ming ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CONTROLLED STUDY; HISTIOCYTE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE; LYMPHOID CELL; LYMPHOID TISSUE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REED STERNBERG CELL; SUCROSE GRADIENT;

ACTINS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; HEAT-SHOCK PROTEINS; HODGKIN DISEASE; HUMANS; IMMUNOBLOTTING; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; LYMPHOMA, NON-HODGKIN; PROTEIN BINDING; REED-STERNBERG CELLS; TISSUE DISTRIBUTION; TONSIL; TUMOR CELLS, CULTURED;

EID: 0032403161     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Kurtz, S., Rossi, J., Petko, L., and Lindquist, S. An ancient developmental induction: heat shock proteins induced in sporulation and oogenesis. Science (Washington DC), 231: 1154-1157, 1986.
2. Lindquist, S. The heat shock response. Annu. Rev. Biochem., 55: 1151-1191, 1986.
3. Craig, E. A. The heat shock response. CRC Crit. Rev. Biochem., 18: 239-280, 1985.
4. Lanks, K. W. Modulators of the eukaryotic heat shock response. Exp. Cell Res., 165: 1-10, 1986.
5. Kennedy, P. G., LaThangue, N. B., Chan, W. L., and Clements, G. B. Cultured human neural cells accumulate a heat-shock protein during acute herpes simplex virus infection. Neurosci. Lett., 61: 321-326, 1985.
6. Zerbini, M., Musiani, M., and La Placa, M. Stimulating effect of heat shock on the early stage of human cytomegalovirus replication cycle. Virus Res., 6: 211-216, 1986.
7. Bardwell, J. C., and Craig, E. A. Eukaryotic Mr 83,000 heat shock protein has a homologue in Escherichia coli. Proc. Natl. Acad. Sci. USA. 84: 5177-5181, 1987.
8. Ciocca, D. R., Oesterreich, S., Chamness, G. C., McGuire, W. L., and Fuqua, S. A. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J. Natl. Cancer Inst., 85: 1558-1570, 1993.
9. Burel, C., Mezger, V., Pinto, M., Rallu, M., Trigon, S., and Morange, M. Mammalian heat shock protein families. Expression and functions. Experientia (Basel), 48: 629-634, 1992.
10. Georgopoulos, C., and Welch, W. J. Role of the major heat shock proteins as molecular chaperones. Cell Biol., 9: 601-634, 1993.
11. Morimoto, R. I., Tissieres, A., and Georgopoulos, C. (eds.). Stress Proteins in Biology and Medicine. Cold Spring Harbor, MI: Cold Spring Harbor Laboratory Press, 1990.
12. Chen, C-F., Chen, Y., Dai, K., Chen, P-L., Riley, D. J., and Lee, W-H. A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol. Cell. Biol., 16: 4691-4699, 1996.
13. Sepehrnia, B., Paz, I. B., Dasgupta, G., and Momand, J. Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell. J. Biol. Chem., 271: 15084-15090, 1996.
14. r 27,000 heat shock protein. Cancer Res., 51: 5245-5252, 1991.
15. Mehlen, P., Schulze-Osthoff, K., and Arrigo, A-P. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J. Biol. Chem., 271: 16510-16514, 1996.
16. Chant, I. D., Rose, P. E., and Morris, A. G. Susceptibility of AML cells to in vitro apoptosis correlates with heat shock protein 70 (hsp70) expression. Br. J. Haematol., 93: 898-902, 1996.
17. Strahler, J. R., Kuick, R., Eckerskorn, C., Lottspeich, F., Richardson, B. C., Fox, D. A., Stoolman, L. M., Hanson, C. A., Nichols, D., and Tueche, H. J. Identification of two related markers for common acute lymphoblastic leukemia as heat shock proteins. J. Clin. Invest., 85: 200-207, 1990.
18. Hanash, S. M., Kuick, R., Strahler, J. R., Richardson, B., Reaman, G., Stoolman, L., Hanson, C., Nichols, D., and Tueche, H. J. Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children. Blood, 73: 727-532, 1989.
19. Osterreich S, Hilsenbeck, S. G., Ciocca, D. R., Allred, C., Clark, G. M., Chamness, G. C., Osborne, C. K., and Fuqua, A. W. The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients. Clin. Cancer Res., 2: 1199-1206, 1966.
20. Ciocca, D. R., Green, S., Elledge, R. M., Clark, G. M., Pugh, R., Ravdin, P., Lew, D., Martino, S., and Osborne, C. K. Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study). Clin. Cancer Res., 5: 1263-1266, 1988.
21. Ullrich, S. J., Robinson, E. A., and Appella, E. Characterization of a chemically homogeneous tumor antigen from a methylcholanthrene-induced sarcoma. Meth A. Mol. Immunol., 23: 545-555, 1986.
22. Ullrich, S. J., Robinson, E. A., Law, L. W., Willingham, M., and Appella, E. A. Mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc. Natl. Acad. Sci. USA, 83: 3121-3125, 1986.
23. DuBois, G. C., Law, L. W., and Appella, E. Purification and biochemical properties of tumor-associated transplantation antigens from methylcholanthrene-induced murine sarcomas. Proc. Natl. Acad. Sci. USA, 79: 7669-7673, 1982.
24. Furman, W. L., Rettenmier, C. W., Chen, J. H., Roussel, M. F., Quinn, C. O., and Sherr, C. J. Antibodies to distal carboxyl terminal epitopes in the v-fms coded glycoprotein do not cross-react with the c-fms gene product. Virology, 152: 432-445, 1986.
25. Hsu, S-M., and Raine, L. Use of avidin-biotin-peroxidase complex (ABC) in pathology. In: R. A. DeLellis (ed.), Advances in Immunohistochemistry, pp. 31-42. Masson Publishers, 1984.
26. Hsu, S-M., and Hsu, P-L. Phenotypes and phorbol ester-induced differentiation of human histiocytic lymphoma cell lines (U-937 and SU-DHL-1) and Reed-Sternberg cells. Am. J. Pathol., 122: 223-230, 1986.
27. Hsu, S-M., Zhao, X., Hsu, P-L., and Lok, M. S. Extracellular matrix does not induce the proliferation, but promotes the differentiation of Hodgkin's cell line HDLM-1. Am. J. Pathol., 127: 9-14, 1987.
28. Epstein, A. L., and Kaplan, H. S. Biology of the human malignant lymphomas. I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas. Cancer (Phila.), 34: 1851-1872, 1974.
29. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
30. Courtneidge, S. A., and Bishop, J. M. Transit of pp60v to the plasma membrane. Proc. Natl. Acad. Sci. USA, 79: 7117-7121, 1982.
31. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
32. Bardella, L., Cajone, F., Cairo, G., Schiaffonati, L., and Bernelli-Zazzera, A. Synthesis of heat-shock proteins and tumor growth. Toxicol. Pathol., 14: 353-356, 1986.
33. Tomasovic, S. P., and Welch, D. R. Heat stress proteins and experimental cancer metastasis. Int. J. Hyperth., 2: 253-266, 1986.
34. Sutherland, R., Freyer, J., Mueller-Klieser, W., Wilson, R., Heacock, C., Sciandra, J., and Sordat, B. Cellular growth and metabolic adaptations to nutrient stress environments in tumor microregions. Int. J. Radiat. Oncol. Biol. Phys., 12: 611-615, 1986.
35. Hall, T. J. Role of hsp70 in cytokine production. Experientia Basel), 50: 1048-1053, 1994.
36. Fincato, G., Polentarutti, N., Sica, A., Mantovani, A., and Colotta, F. Expression of a heat-inducible gene of the HSP70 family in human myelomonocytic cells: regulation by bacterial products and cytokines. Blood, 77: 579-586, 1991.
37. Hsu, S-M., Waldron, A. J., Xie, S-S., and Hsu, P-L. Hodgkin's disease and anaplastic large cell lymphoma revisited-I. Unique cytokine and cytokine receptor profile distinguished from that of non-Hodgkin's lymphomas. J. Biomed. Sci., 2: 302-313, 1995.
38. Hsu, S-M., Waldron, A-J., Xie, S-S., and Hsu, P-L. Hodgkin's disease and anaplastic large cell lymphoma revisited-II. From cytokines to cell lineage. J. Biomed. Sci., 3: 1-13, 1996.
39. Brugge, J., Yonemoto, W., and Darrow, D. Interaction between the Rous sarcoma virus transforming protein and two cellular phosphoproteins: analysis of the turnover and distribution of this complex. Mol. Cell. Biol., 3: 9-19, 1983.
40. Brugge, J. S., Darrow, D., Lipsich, L. A., and Yonemoto, W. The association of the transforming protein of Rous sarcoma virus with two cellular phosphoproteins. Prog. Clin. Biol. Res., 119: 135-147, 1983.
41. Schuh, S., Yonemoto, W., Brugge, J., Riehl, R. M., Sullivan, W. P., and Toft, D. O. A 90,000-dalton binding protein common to both steroid receptors and the Rous sarcoma virus transforming protein, pp60v. J. Biol. Chem., 260: 14292-14296, 1985.
42. Ziemiecki, A., Catelli, M. G., Joab, I., and Moncharmont, B. Association of the heat shock protein hsp90 with steroid hormone receptors and tyrosine kinase oncogene products. Biochem. Biophys. Res. Commun., 138: 1298-1307, 1986.
43. Catelli, M. G., Binart, N., Jung-Testas, I., Renoir, J. M., Baulieu, E. E., Feramisco, J. R., and Welch, W. J. The common 90-kDa protein component of non-transformed '8S' steroid receptors is a heat-shock protein. EMBO J., 4: 3131-3135, 1985.
44. Koyasu, S. R., Nishida, E., Kadowaki, T., Matsuzaki, F., Iida, K., Harada, F., Kasuga, M, Sakai, H., and Yahara, I. Two mammalian heat shock proteins, HSP90 and HSP100, are actin-binding proteins. Proc. Natl. Acad. Sci. USA, 83: 8054-8058, 1986.
45. Nishida, E., Koyasu, S., Sakai, H., and Yahara, I. Calmodulin-regulated binding of the 90-kDa heat shock protein to actin filaments. J. Biol. Chem., 261: 16033-16036, 1986.
46. Fisher, R. I. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease. Cancer Treat. Rep., 66: 681-687, 1982.
47. Pierce, S. K. Molecular chaperones in the processing and presentation of antigen to helper T cells. Experientia, 50: 1026-1030, 1994.
48. Doussis-Anagnostopoulou, I., Remadi, S., Kaklammanis, L., Pessella, F., and Gatter, K. C. Detection of p53 in Hodgkin's disease using the monoclonal antibody PAb248. J. Pathol., 178: 170-172, 1996.
49. Xeri, L., Parc, P., Bouabdallah, R., Camerlo, J., and Hassoun, J. PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease. J. Pathol., 175: 189-194, 1995.
50. Chilosi, M., Doglioni, C., Meenestrina, F., Montagna, L., Rigo, A., Lestani, M., Barbareschi, M., Scarpa, A., Mariuzzi, G. M., and Pizzolo, G. Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease. Blood, 84: 4295-4300, 1994.